首页 › 基金 › ACT CAPITAL MANAGEMENT, LLC › KRYS
ACT CAPITAL MANAGEMENT, LLC 对 KRYS 的持仓历史
KRYSTAL BIOTECH INC · 医疗保健
ACT CAPITAL MANAGEMENT, LLC 在 Q2 2026 的 13F 申报中披露持有 KRYS(KRYSTAL BIOTECH INC)45,000 股,市值约 US$16.7M,约占其申报组合的 10.93%,在其申报持仓中市值排名第 1 位。 ACT CAPITAL MANAGEMENT, LLC 最近 3 个申报季度中有 3 个季度披露了 KRYS 持仓,最早可追溯至 Q4 2025。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
ACT CAPITAL MANAGEMENT, LLC 对 KRYS 的持仓演变
ACT CAPITAL MANAGEMENT, LLC 于 Q4 2025 首次披露 KRYS 持仓:60,500 股(约 US$14.9M)。 该持仓在 Q2 2026 达到峰值 45,000 股,市值约 US$16.7M。 在 3 次申报中,ACT CAPITAL MANAGEMENT, LLC 0 次增持、1 次减持、1 次保持不变。 最近一期申报(Q2 2026)显示持股 45,000 股、市值约 US$16.7M,环比减持 -15,477 股。。 持仓曾出现大幅变动:Q2 2026 减持约 26% (随后一个季度股价下跌 11%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2025 | 60.50K | $14.92M | 新进 |
| Q1 2026 | 60.48K | $15.62M | 持有 |
| Q2 2026 | 45.00K | $16.73M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 KRYS 与 13F 数据
KRYS(KRYSTAL BIOTECH INC)属于医疗保健行业。我们追踪的基金中还有 49 只申报持有 KRYS,申报仓位最大的包括:Avoro Capital Advisors LLC (US$1.07B), Soleus Capital Management, L.P. (US$349.1M), Hood River Capital Management LLC (US$246.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 KRYS 的基金
- Avoro Capital Advisors LLC 2.89M 股 · $1.07B · Q2 2026
- Soleus Capital Management, L.P. 939.25K 股 · $349.09M · Q2 2026
- Hood River Capital Management LLC 663.38K 股 · $246.56M · Q2 2026
- Redmile Group, LLC 632.00K 股 · $234.90M · Q2 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 570.15K 股 · $211.91M · Q2 2026
- Frazier Life Sciences Management, L.P. 481.31K 股 · $178.89M · Q2 2026
- VESTOR CAPITAL, LLC 700.91K 股 · $78.19M · Q2 2026
- BRAIDWELL LP 128.97K 股 · $47.94M · Q2 2026
更多关于 ACT CAPITAL MANAGEMENT, LLC
常见问题
How long has ACT CAPITAL MANAGEMENT, LLC held KRYS?
ACT CAPITAL MANAGEMENT, LLC has disclosed KRYS holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is ACT CAPITAL MANAGEMENT, LLC's current position in KRYS?
As of Q2 2026, ACT CAPITAL MANAGEMENT, LLC holds 45.00K shares of KRYS (KRYSTAL BIOTECH INC), valued at $16.73M, representing 10.93% of its reported portfolio and ranking #1.
Has ACT CAPITAL MANAGEMENT, LLC been buying or selling KRYS?
In the latest 13F filing (Q2 2026), ACT CAPITAL MANAGEMENT, LLC reduced its position in KRYS. The position peaked in Q2 2026 at 45.00K shares.
Which other funds hold KRYS?
Other major institutional holders of KRYS include Avoro Capital Advisors LLC, Soleus Capital Management, L.P., Hood River Capital Management LLC, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.